Quest Diagnostics and Fitbit announce collaboration to study wearable devices

Fitbit and Quest Diagnostics announced a collaboration to study the potential of wearable devices to improve metabolic health, which influences risk of developing several diseases, including diabetes and heart disease. The Wearables for Metabolic Health pilot study will pair behavioral and biometric data from Fitbit devices with health insights from Quest Diagnostics’ laboratory tests to explore ways data can be combined and analyzed to improve the assessment and management of metabolic health and help to inform the prevention of disease. The IRB approved study will invite approximately 1,500 existing Fitbit users to join and consent to share three months of their Fitbit data. They will also be given the opportunity to receive laboratory testing at no cost using a panel of blood tests specifically designed to assess metabolic health, including blood sugar, cholesterol and triglycerides. The WEAR-ME pilot study is expected to be completed in 2024.